Compare Nutrien Ltd (NTR) vs Sana Biotechnology Inc (SANA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nutrien Ltd vs Sana Biotechnology Inc — how do they compare? Nutrien Ltd trades at $66.8 (market cap $31.67B), while Sana Biotechnology Inc trades at $3.17 (market cap $873.84M). The key difference: Nutrien Ltd is far larger — about 36.2× Sana Biotechnology Inc's market cap, and Nutrien Ltd pays a 3.3% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| NTR | SANA | |
|---|---|---|
Market Cap | $31.67B | $873.84M |
Sector | Basic Materials | Health |
52-Week High | $83.94 | $5.92 |
52-Week Low | $53.64 | $2.68 |
Enterprise Value | $44.84B | $848.03M |
Dividend Yield | 3.3% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nutrien Ltd
Created in 2018 as a result of the merger between PotashCorp and Agrium, Nutrien is the world's largest fertilizer producer by capacity. Nutrien produces the three main crop nutrients--nitrogen, potash, and phosphate--although its main focus is potash, where it is the global leader in installed capacity with roughly 20% share. The company is also the largest agricultural retailer in the United States, selling fertilizers, crop chemicals, seeds, and services directly to farm customers through its brick-and-mortar stores and online platforms.
Read more on NTR →About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →
